Pharmacologic evidence for abnormal thalamocortical functioning in GABA receptor beta3 subunit-deficient mice, a model of Angelman syndrome. [electronic resource]
Producer: 20060124Description: 1860-70 p. digitalISSN:- 0013-9580
- Angelman Syndrome -- drug therapy
- Animals
- Anticonvulsants -- pharmacology
- Baclofen -- pharmacology
- Cerebral Cortex -- drug effects
- Disease Models, Animal
- Electrodes, Implanted
- Electroencephalography -- drug effects
- Ethosuximide -- pharmacology
- Female
- GABA Agonists -- pharmacology
- GABA Antagonists -- pharmacology
- Humans
- Male
- Mice
- Mice, Mutant Strains
- Neural Pathways -- physiopathology
- Organophosphorus Compounds -- pharmacology
- Parietal Lobe -- physiopathology
- Receptors, GABA-A -- deficiency
- Thalamus -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.